Transposable elements in the dark genome - Nature

Vir Biotechnology earnings: Losses persist as hepatitis program advances By Investing.com - Investing.com Canada

Global Biotechnology Market Size and Forecast 2025–2033 - vocal.media

Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors - Business Wire

CStone wins UK clearance for sugemalimab in lung cancer - The Pharma Letter

Cizzle Biotechnology's Partner in Final Stages of CLIA Process for CIZ1B Biomarker in US - marketscreener.com

Cizzle Biotechnology secures additional US$3.5 million in guaranteed royalties as US launch nears - Proactive Investors

Hanoi approves land lease for phase 2 of $1 bln biotechnology high-tech park - Theinvestor.vn

Cizzle Biotechnology Nears CLIA Accreditation For Early Lung Cancer Test - DirectorsTalk Interviews

[News] ams OSRAM and Ziwooo Biotechnology Announce Strategic Brand Licensing Partnership for Health & Beauty Products in APAC - LEDinside

Biotechnology is set to drive the evolution of personalised medicine, say experts - The Hindu

Horizon Health Biotech Analytics Ethics Guidelines Biotechnology Market Size And Share | Industry Report, 2030 Horizon Health Biotech Analytics Ethics Program Australia - inva.kz

Generative AI and precision medicine fuel rapid growth in biotechnology sector - MSN

Vir Biotechnology Inc expected to post a loss of 49 cents a share - Earnings Preview - TradingView

Arvinas, Inc. (ARVN) Stock Analysis: Unlocking Potential in Biotechnology with an 8.52% Upside - DirectorsTalk Interviews